Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cassava Sciences
Biotech
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Galapagos CEO eyes exit as spinout names leader. Longtime NIH leader set to retire as chief of staff. Lilly exec jumps to Zealand.
Darren Incorvaia
,
Zoey Becker
Apr 25, 2025 8:30am
Cassava stops Alzheimer's program as simufilam fails again
Mar 25, 2025 9:12am
2024's top 10 clinical trial flops
Feb 18, 2025 3:00am
Cassava cuts 3rd of staff in wake of phase 3 Alzheimer's fail
Jan 8, 2025 3:38am
Fierce Biotech's Rotten Tomatoes of 2024
Dec 16, 2024 3:00am
Cassava flunks phase 3 Alzheimer's test, stops 2nd trial
Nov 25, 2024 8:45am
